ICYMI: Neurotrack got a shoutout on Squawk Box as the kind of diagnostic tool the heathcare system needs, now that Alzheimer's drugs have shaken up the longevity sector. Thanks, Abby Miller Levy of #PrimetimePartners!

Live, from New York, it's Neurotrack! Exciting to see Neurotrack's name on the big screen in Times Square Tuesday as part of the GS Impact/100 2023 – an annual list of up-and-coming impact companies with the power to "fix the future." So grateful for the recognition 🙏

Whose line is it, anyway? Should patients or PCPs be the first to bring up memory issues? 🤐 This awkward standoff is a major contributor to underdiagnosis, and it's time to put an end to it. Read more on the Neurotrack blog: hubs.ly/Q0207J-h0

📣 Catch our CEO Elli Kaplan at #hlth2023 on 10/8. Her panel is on neurodegenerative diseases, including #alzheimers, and... 🧠 progress in diagnosis and intervention 🧠 the next big breakthroughs 🧠 important work that still must be done HLTH hubs.la/Q0221Y6k0

How did Neurotrack's cognitive battery perform in Japan? Subarashikatta! 🇯🇵 When you design a digital assessment tool to be culturally agnostic and optimized for older users in any language, it stays sensitive and specific in every setting. Read more: hubs.la/Q0221_jk0

🛫 Catch us if you can! It’s conference season for Neurotrack and we look forward to connecting with healthcare leaders, industry colleagues, and journalists at each of these upcoming events. Reach out to schedule a meet up.

Are you familiar with MEG3? It’s a molecule produced by brain cells in the face of amyloid and tau build up -- and it triggers cell death. In new research from the UK and Belgium, once MEG3 was blocked, brain cells lived. Learn more from the BBC News: hubs.la/Q022mpNG0

#DTxEast day 2 here we go! Yesterday we closed off at the "Breaking Down the Wall of Provider & Patient Adoption of DTx: What’s Still Stopping Us?" panel discussion.

Team Neurotrack had a blast discussing our digital cognitive assessments with the incredible #healthcare pros at the Optum Health Education National Conference. Optum is a leading care delivery org with 70,000+ doctors serving 101 million patients across 2000 sites.

See you at #HLTH2023! Try our cognitive screening tool, enter a prize drawing, and more at Neurotrack's kiosk in the MATTER Pavilion. Visit the Sky Stage on Sunday at 2:50 where Elli Kaplan will discuss the progress we're making in #Alzheimers & other neurodegenerative disease.

DYK: Up to 2/3 of women notice cognitive changes in menopause & brain fog is the #2 complaint of women at virtual clinic Midi Health. Our Elli Kaplan stopped by the HotFlashesCoolTopics pod to talk women's brain health. Give it a listen for #WorldMenopauseDay: go.neurotrack.io/wmd

Jaw-dropping stats from USC, but we have a solution. Neurotrack's digital screener identifies cognitive impairment in as little as 3 minutes. Our FDA-registered, first-of-its-kind tool has been in clinical use for a year with major health delivery orgs. Haley Weiss

Upbeat weekend read on palpable optimism at the CTAD from Bloomberg reporters Robert Langreth  and Gerry Smith. Promising drug news from Eisai US, Eli Lilly and Company , Biogen, and Roche, too: bit.ly/3Qgs8Ox

#Medicare "cognitive assessment and care plan services" usage tripled from 2018 to 2022, but only 2.4% of Alzheimer's-diagnosed beneficiaries accessed these crucial services in 2021. 🤔Neurotrack's workflow-friendly cognitive screening tools support utilization. 🧠💙